Mutations of PPP2R1A promote cells proliferation by upregulating the phosphorylation levels of Akt, ERK, and WNK1 in gastrointestinal stromal tumors and by interactions with the PP2A inhibitor TIPRL1 in uterine cancer (17,18). Here, TIPRL is linked to gastrointestinal stromal tumor.